medigraphic.com
SPANISH

Archivos de Cardiología de México

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2006, Number S2

<< Back

Arch Cardiol Mex 2006; 76 (S2)

Guidelines of the national institute of cardiology “Ignacio Chávez” for the treatment of systemic arterial hypertension

Mendoza GC
Full text How to cite this article

Language: Spanish
References: 6
Page: 279-284
PDF size: 89.98 Kb.


Key words:

Systemic arterial hypertension, Treatment guidelines, Cardiovascular risk.

ABSTRACT

The arterial hypertension in Mexico has a prevalence of 30 %, with some differences in the geographical distribution. Of this population two relevant aspects are outlined: the high prevalence of arterial hypertension in young people and the common association with other factors of cardiovascular risk. Associated with these facts, it is of be making notice that an important percentage of this people doesn’t know the diagnosis, and that those who have this diagnosis established often does not receive treatment or, has an evil control of the value of the arterial tension them in spite of receiving pharmacological treatment. The guidelines for the treatment of the arterial hypertension in our country are based on anatomic characteristics proper of our population, and they are based in a process of risk stratification elaborated with the same characteristics. These guidelines are the recommendations for the initial treatment of the arterial hypertension but must be remembered the fundamental concept of the medicine that establishes that any treatment must be completely individualized.


REFERENCES

  1. Causas de mortalidad en México 2000. Estadísticas de Mortalidad, Secretaría de Salud. http://www.ssa.gob.mx.

  2. VELÁSQUEZ MO, ROSAS PM, LARA EA ET AL: Hipertensión Arterial en México: Resultados de la encuesta Nacional de Salud (ENSA) 2000. Arch Cardiol Mex 2002; 72: 71-84.

  3. ROSAS PM, LARA EA, PASTELÍN HG, ET AL: Reencuesta Nacional de Hipertensión Arterial (RENAHTA): Consolidación Mexicana de los factores de riesgo cardiovascular: Cohorte Nacional de Seguimiento. Arch Cardiol Mex 2005; 75: 96-111.

  4. WHITWORTH JA; World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO) /International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003; 21: 1983-1992.

  5. VELÁSQUEZ MO, ROSAS PM, LARA EA, ET AL: Prevalencia e interrelación de las enfermedades crónicas no transmisibles y factores de riesgo cardiovascular en México. Arch Cardiol Mex 2003; 73: 62-77.

  6. ROSAS MP: Guías Prácticas para la detección, prevención, diagnóstico y tratamiento de Hipertensión Arterial Sistémica en México. Instituto Nacional de Cardiología “Ignacio Chávez”, 2005.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Arch Cardiol Mex. 2006;76